TY - JOUR
T1 - Evaluation of Apigenin Inhibiting Lactate Dehydrogenase Activity Based on CdTe Quantum Dots Fluorescence
AU - Ren, Xiangling
AU - Liu, Meijia
AU - Tang, Ming
AU - Tan, Longfei
AU - Fu, Changhui
AU - Wu, Qiong
AU - Li, Hongbo
AU - Chen, Yi
AU - Chen, Lufeng
AU - Meng, Xianwei
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Lactate dehydrogenase (LDH) is one of key enzymes in glucose metabolism pathway, which plays a critical role in cell metabolism. Inhibition of LDH can inhibit glycolysis process, thereby inhibiting the occurrence and development of tumor cells. Two kinds of LDH inhibitors, apigenin and emodin, were obtained by testing the IC50 of several natural products in LDH enzyme reaction. The IC50 of apigenin was about 1/3 of LDH inhibitor sodium oxalate. A new method to evaluate the performance of LDH inhibitors based on CdTe QDs was established at the same time, which provides a new idea for research on LDH enzyme inhibitors.
AB - Lactate dehydrogenase (LDH) is one of key enzymes in glucose metabolism pathway, which plays a critical role in cell metabolism. Inhibition of LDH can inhibit glycolysis process, thereby inhibiting the occurrence and development of tumor cells. Two kinds of LDH inhibitors, apigenin and emodin, were obtained by testing the IC50 of several natural products in LDH enzyme reaction. The IC50 of apigenin was about 1/3 of LDH inhibitor sodium oxalate. A new method to evaluate the performance of LDH inhibitors based on CdTe QDs was established at the same time, which provides a new idea for research on LDH enzyme inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=85120661304&partnerID=8YFLogxK
U2 - 10.1166/jbn.2021.3158
DO - 10.1166/jbn.2021.3158
M3 - Article
C2 - 34688325
AN - SCOPUS:85120661304
SN - 1550-7033
VL - 17
SP - 1806
EP - 1811
JO - Journal of Biomedical Nanotechnology
JF - Journal of Biomedical Nanotechnology
IS - 9
ER -